News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
329,339 Results
Type
Article (17856)
Company Profile (314)
Press Release (311161)
Multimedia
Podcasts (79)
Webinars (12)
Section
Business (95413)
Career Advice (217)
Deals (16811)
Drug Delivery (47)
Drug Development (57279)
Employer Resources (41)
FDA (6823)
Job Trends (6459)
News (171398)
Policy (11995)
Tag
Academia (996)
Accelerated approval (18)
Adcomms (14)
Allergies (79)
Alliances (24658)
ALS (132)
Alzheimer's disease (1133)
Antibody-drug conjugate (ADC) (242)
Approvals (7049)
Artificial intelligence (264)
Autoimmune disease (107)
Automation (10)
Bankruptcy (121)
Best Places to Work (5559)
BIOSECURE Act (7)
Biosimilars (123)
Biotechnology (239)
Bladder cancer (106)
Brain cancer (45)
Breast cancer (378)
Cancer (3352)
Cardiovascular disease (256)
Career advice (199)
Career pathing (9)
CAR-T (236)
CDC (6)
Cell therapy (603)
Cervical cancer (19)
Clinical research (49249)
Collaboration (1125)
Company closure (3)
Compensation (690)
Complete response letters (35)
COVID-19 (1236)
CRISPR (85)
C-suite (531)
Cystic fibrosis (124)
Data (4571)
Decentralized trials (1)
Denatured (13)
Depression (88)
Diabetes (278)
Diagnostics (2095)
Digital health (12)
Diversity (6)
Diversity, equity & inclusion (10)
Drug discovery (186)
Drug pricing (54)
Drug shortages (5)
Duchenne muscular dystrophy (208)
Earnings (40356)
Editorial (25)
Employer branding (8)
Employer resources (38)
Events (60586)
Executive appointments (663)
FDA (8660)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (999)
Gene editing (184)
Generative AI (22)
Gene therapy (497)
GLP-1 (611)
Government (1298)
Grass and pollen (3)
Guidances (219)
Healthcare (7737)
HIV (28)
Huntington's disease (40)
IgA nephropathy (76)
Immunology and inflammation (205)
Immuno-oncology (29)
Indications (55)
Infectious disease (1371)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (48)
Intellectual property (166)
Interviews (23)
IPO (9032)
IRA (21)
Job creations (1229)
Job search strategy (175)
Kidney cancer (9)
Labor market (27)
Layoffs (361)
Leadership (14)
Legal (1734)
Liver cancer (55)
Longevity (9)
Lung cancer (461)
Lymphoma (285)
Machine learning (25)
Management (11)
Manufacturing (394)
MASH (141)
Medical device (3218)
Medtech (3234)
Mergers & acquisitions (8463)
Metabolic disorders (801)
Multiple sclerosis (113)
NASH (14)
Neurodegenerative disease (232)
Neuropsychiatric disorders (72)
Neuroscience (2054)
NextGen: Class of 2025 (2322)
Non-profit (984)
Now hiring (28)
Obesity (371)
Opinion (152)
Ovarian cancer (136)
Pain (104)
Pancreatic cancer (156)
Parkinson's disease (222)
Partnered (15)
Patents (320)
Patient recruitment (319)
Peanut (44)
People (30418)
Pharmaceutical (50)
Pharmacy benefit managers (8)
Phase I (17022)
Phase II (22718)
Phase III (15020)
Pipeline (3093)
Policy (103)
Postmarket research (960)
Preclinical (7060)
Press Release (32)
Prostate cancer (155)
Psychedelics (49)
Radiopharmaceuticals (262)
Rare diseases (628)
Real estate (1782)
Recruiting (17)
Regulatory (11432)
Reports (20)
Research institute (1055)
Resumes & cover letters (25)
Rett syndrome (21)
RNA editing (16)
RSV (32)
Schizophrenia (130)
Series A (185)
Series B (129)
Service/supplier (2)
Sickle cell disease (86)
Special edition (17)
Spinal muscular atrophy (124)
Sponsored (16)
Startups (2233)
State (1)
Stomach cancer (5)
Supply chain (39)
Tariffs (25)
The Weekly (65)
Vaccines (468)
Venture capital (66)
Weight loss (212)
Women's health (36)
Worklife (2)
Date
Last 7 days (249)
Last 30 days (1535)
Last 365 days (21164)
2025 (21111)
2024 (23715)
2023 (26007)
2022 (31456)
2021 (32380)
2020 (27256)
2019 (19206)
2018 (14147)
2017 (16684)
2016 (14150)
2015 (17049)
2014 (12164)
2013 (8702)
2012 (8919)
2011 (9166)
2010 (8903)
Location
Africa (202)
Alabama (66)
Alaska (2)
Arizona (76)
Arkansas (5)
Asia (21765)
Australia (3740)
California (7667)
Canada (1957)
China (811)
Colorado (242)
Connecticut (298)
Delaware (244)
Europe (47629)
Florida (927)
Georgia (232)
Hawaii (2)
Idaho (19)
Illinois (407)
India (34)
Indiana (211)
Iowa (9)
Japan (277)
Kansas (80)
Kentucky (9)
Louisiana (8)
Maine (11)
Maryland (836)
Massachusetts (5957)
Michigan (116)
Minnesota (254)
Mississippi (3)
Missouri (42)
Montana (17)
Nebraska (5)
Nevada (39)
New Hampshire (18)
New Jersey (1976)
New Mexico (15)
New York (1952)
North Carolina (868)
North Dakota (6)
Northern California (3801)
Ohio (180)
Oklahoma (13)
Oregon (23)
Pennsylvania (1330)
Puerto Rico (10)
Rhode Island (26)
South America (275)
South Carolina (12)
Southern California (2945)
Tennessee (47)
Texas (1001)
United States (25372)
Utah (124)
Virginia (156)
Washington D.C. (43)
Washington State (603)
West Virginia (1)
Wisconsin (70)
Wyoming (1)
329,339 Results for "pipeline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Werewolf Therapeutics Announces Pipeline and Business Updates
December 19, 2025
·
10 min read
Press Releases
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
December 16, 2025
·
4 min read
Press Releases
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
December 16, 2025
·
5 min read
Press Releases
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
December 24, 2025
·
3 min read
Funding
Artios Pushes Cancer Pipeline Forward With $115M Series D
Artios Pharma is working on a pipeline of oncology assets, led by alnodesertib, currently being tested for second-line pancreatic cancer and third-line colorectal cancer.
November 17, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
November 14, 2025
·
17 min read
Press Releases
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
November 10, 2025
·
12 min read
Press Releases
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
October 23, 2025
·
5 min read
Press Releases
Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes
December 19, 2025
·
1 min read
Press Releases
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
November 10, 2025
·
14 min read
1 of 32,934
Next
